Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2018 07:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine

CMV neutralizing antibodies against fibroblast cell infection induced in 100% of subjects who received the highest doseSafe and well-tolerated at all doses with no safety signals observedConference...